Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Adaptilens logo — The first biomimetic accommodating IOL

Adaptilens

The first biomimetic accommodating IOL

Founded 2019 United States Newton, United States 9 employees Series A Total: $19.10M Health Care, Medical Devices

General Information

Company Name Adaptilens
Founded Year 2019
Location United States Newton, United States +1
Employees 9
Industries Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when Adaptilens moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Adaptilens

Adaptilens, founded in 2019 and headquartered in the United States, operates at the intersection of the Health Care and Medical Devices industries. The company is pioneering a transformative approach to vision correction with its flagship product, the Adaptilens accommodating intraocular lens (A-IOL).

With its slogan, "The first biomimetic accommodating IOL," Adaptilens aims to restore youthful vision by imitating the natural lens of a healthy young eye. The A-IOL mimics the eye’s natural accommodation response, allowing users to see clearly at various distances without glasses.

In April 2024, Adaptilens successfully secured a $17.50M Series A investment from notable investors including Pillar, Perceptive Advisors, 380 Cap, and Accanto Partners. This significant investment underscores confidence in Adaptilens' innovative potential in addressing a critical need in eye care technology.

Taxonomy: ophthalmology, cataract surgery, IOL technology, vision correction, eye care innovation, innovative polymers, lens technology, vision enhancement, eye surgery, medical device innovation

Services & Products

development of accommodating intraocular lenses
vision correction solutions
restoration of youthful vision

Target Customers

cataract patients ophthalmologists refractive and cataract surgeons senior citizens experiencing vision loss

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor Investor
01 Apr 2024
Seed •••••• 2
Investor Investor
01 Nov 2020

Adaptilens Alternatives & Competitors

Adaptilens vs
Daniel Goodman, M.D.
Daniel Goodman, M.D. United States

Comprehensive vision care for all ages, featuring advanced procedures for cataract, LASIK, and corne...

10 employees
Fashion, Health Care
Adaptilens vs
EYE PCR BV
EYE PCR BV The Netherlands

Our mission: bring extraordinary science to life-changing therapies for patients with eye disorders

9 employees
Health Care, Medical Devices
Adaptilens vs
PowerVision, Inc.
PowerVision, Inc. United States

Restoring True Vision for All Distances

Series D
13 employees
Biotechnology, Health Care

FAQ About Adaptilens

The first biomimetic accommodating IOL
Adaptilens was founded in 2019.
Adaptilens is headquartered in Newton, United States.
Adaptilens operates in the following industries: Health Care, Medical Devices.
Adaptilens has approximately 9 employees.
Adaptilens has completed 2 funding rounds, raising a total of $19.10M. The latest funding stage is Series A.
Adaptilens offers: development of accommodating intraocular lenses, vision correction solutions, restoration of youthful vision.
Top alternatives and competitors to Adaptilens include Daniel Goodman, M.D., EYE PCR BV, PowerVision, Inc., Southern Eye​ Center, Florida Vision Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Adaptilens and Daniel Goodman, M.D. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Adaptilens and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy